Literature DB >> 14586868

Avascular necrosis of the jaws: risk factors in metastatic cancer patients.

Peter Tarassoff, Katalin Csermak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14586868     DOI： 10.1016/j.joms.2003.09.001

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  26 in total

1.  Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis.

Authors:  Christian Walter; Knut A Grötz; Martin Kunkel; Bilal Al-Nawas
Journal:  Support Care Cancer       Date:  2006-08-29       Impact factor: 3.603

2.  [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].

Authors:  S Hoefert; H Eufinger
Journal:  Mund Kiefer Gesichtschir       Date:  2005-07

3.  Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.

Authors:  Salvatore Ruggiero; Julie Gralow; Robert E Marx; Ana O Hoff; Mark M Schubert; Joseph M Huryn; Bela Toth; Kathryn Damato; Vicente Valero
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

Review 4.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

5.  [Necrosis of the jaws under bisphosphonate therapy].

Authors:  S Hoefert; H Eufinger
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

6.  Osteonecrosis of the jaw in a patient on Denosumab.

Authors:  Tara L Aghaloo; Alan L Felsenfeld; Sotirios Tetradis
Journal:  J Oral Maxillofac Surg       Date:  2010-02-10       Impact factor: 1.895

7.  Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.

Authors:  Tara L Aghaloo; Ben Kang; Eric C Sung; Michael Shoff; Matthew Ronconi; Jack E Gotcher; Olga Bezouglaia; Sarah M Dry; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

8.  Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases.

Authors:  Annalisa Bramati; Serena Girelli; Gabriella Farina; Maria Chiara Dazzani; Valter Torri; Anna Moretti; Sheila Piva; Mariastella Dimaiuta; Nicla La Verde
Journal:  J Bone Miner Metab       Date:  2014-02-20       Impact factor: 2.626

9.  Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up.

Authors:  Philipp Stockmann; Eleftherios Vairaktaris; Falk Wehrhan; Martin Seiss; Stephan Schwarz; Bernd Spriewald; Friedrich-Wilhelm Neukam; Emeka Nkenke
Journal:  Support Care Cancer       Date:  2009-07-17       Impact factor: 3.603

Review 10.  Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature.

Authors:  Jan Rustemeyer; Andreas Bremerich
Journal:  Clin Oral Investig       Date:  2009-06-04       Impact factor: 3.573
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.